Author

Hans Vellama

University of TartuORCID 0009-0003-9950-9789Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:metabolomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Kattri‐Liis EsklaiD· 2 shared Adam BoufersaouiiD· 1 shared Alejandro Huerta UribeiD· 1 shared Andres SalumetsiD· 1 shared Charlotte Speakman· 1 shared Christopher M. BunceiD· 1 shared Cristina Escribano-GonzaleziD· 1 shared Daniel A. TennantiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Kattri‐Liis EsklaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistrybioRxivPreprintOct 13, 2026

Decoupling of CO2 and O2 fluxes reveals oxygen-independent decarboxylation in anoxic mammalian cells

Hans Vellama, Hillar Eichelmann, Uku Gross…·Kattri-Liis Eskla

The paper directly measures CO2 and O2 fluxes in anoxic mammalian cells, revealing oxygen-independent decarboxylation that persists after oxygen removal.

DOI 10.64898/2026.10.10.757797

humanmetabolomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 8, 2024

Pyruvate from bone marrow mesenchymal stem cells supports myeloma redox homeostasis and anabolism

Elías Vera-Sigüenza, Cristina Escribano-Gonzalez, Irene Serrano‐Gonzalo…·Daniel A. Tennant

This study shows that pyruvate from bone marrow mesenchymal stem cells supports myeloma cell redox homeostasis and anabolism through MCT-1/2 transporters.

1 citation

humanmetabolomics

𝕏 PostBluesky

Cancer BiologyScientific ReportsPeer-reviewedFeb 21, 2024

Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines: onametostat reduces proliferation and viability in both normoxic and hypoxic conditions

Darja Lavõgina, Mattias Kaspar Krõlov, Hans Vellama…·Jana Jaal

This study evaluates the efficacy of onametostat, a PRMT5 inhibitor, in reducing glioblastoma cell proliferation and viability under normoxic and hypoxic conditions.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky